Assessment of the Efficacy and Tolerance of Drepanoalpha® in the Management of Sickle Cell Disease in Kinshasa (DR Congo): About Ten Cases
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2017, Vol 9, Issue 2
Abstract
Aims: The aim of this study is to assess the efficacy and safety of Drepanoalpha®, a nutraceutical used in the management of sickle cell disease in DR Congo. Study Design: Drepanoalpha® to ten sickle patients, evaluation of parameters before and after treatment. Place and Duration of Study: Department of Biology, Science faculty, university of Kinshasa, between Sept 2015 and July 2016. Methodology: The ten selected cases were submitted to Drepanoalpha® for two months and the following parameters were observed before, during and after treatment: The hemoglobin rate, the number of crises, biochemical parameters such as the rate of urea, creatinine, bilirubin (total and direct) and transaminases (SGOT and SGPT). A clinical evaluation and monitoring of product safety signs was also carried out. Results: The results show an increase in hemoglobin in all patients ranging from 19.2 to 42.9% and a total stop of crises. The product does not disturb the indicators of liver function (transaminases SGOT and SGPT, total and direct bilirubin) nor those of renal function (urea and creatinine). No adverse effects event such as vomiting, urticaria, pruritus, itching and diarrhea were observed. Conclusion: According to this study, Drepanoalpha® increases the hemoglobin level in subjects treated leading to a cessation of sickle cell crisis. This drug does not alter liver and kidney functions and does not induce side effects in treated subjects, thus ensuring its safety.
Authors and Affiliations
Benjamin Z. Gbolo, Damien S. T. Tshibangu, Patrick Memvanga, Gédéon N. Bongo, Félicien M. Kasali, K. N. Ngbolua, Pius T. Mpiana
Keywords
Related Articles
- EP ID EP309520
- DOI 10.9734/IJMPCR/2017/33658
- Views 111
- Downloads 0
Bactrim-induced Severe Thrombocytopenia in Pregnancy
A 29-year-old Caucasian woman at 30 weeks’ gestation presented with severe and asymptomatic thrombocytopenia with a platelet count of 17 × 109/L after completing 9 days out of a 10-day course of Bactrim DS for a nasal ab...
Seven Year Survival After Multiple Recurrences and Repeated Metastasectomies with Targeted Therapies for Renal Cell Carcinoma
Background: In spite of resistance and limited response to chemotherapy, radiotherapy and immunotherapy, recent advances led to several targeted agents that showed the prolongation of progressive free survival. Due to th...
Bilateral Fibrous Dysplasia of the Upper and Lower Jaws: Case Report
Aim: To present a case with bilateral fibrous dysplasia of the upper and lower jaws. Presentation of Case: A patient had mild pain in the lower jaw without any specific localization. From the patient’s diagnosis, it was...
Mauriac Syndrome in a 35 Year Old Woman With Type One Diabetes Mellitus
Mauriac syndrome is a rare complication of type 1 diabetes mellitus. It is characterized by hepatomegaly, growth delay and the presence of elevated transaminases and serum lipids. Mauriac syndrome occurs in males and fem...
Gingival Overgrowth Associated with Phenytoin Therapy: Report of a Case
Gingival overgrowth (also called gingival hyperplasia, or gingival hypertrophy) refers to an increase in the size of the gingiva. It is seen as an adverse effect of drugs such as anticonvulsants, immunosuppressants, and...